Synthetic heart valves composed of zwitterionic polymers
US-2016296322-A1 · Oct 13, 2016 · US
US11512160B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11512160-B2 |
| Application number | US-201615578633-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 2, 2016 |
| Priority date | Jun 2, 2015 |
| Publication date | Nov 29, 2022 |
| Grant date | Nov 29, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions.
Opening claim text (preview).
The invention claimed is: 1. A bulk material comprising a crosslinked polymer having tensile and compressive strengths greater than about 0.5 MPa and a fibrinogen adsorption of less than about 30 ng/cm 2 in a fibrinogen binding assay when the material is incubated at 37° C. for 90 minutes with a 1.0 mg/ml fibrinogen solution that is 0.15 M phosphate buffered saline at pH 7.4, the crosslinked polymer having a hydrophobic interior comprising (a) a polymer backbone, (b) a plurality of nitrogen centers, each nitrogen center covalently coupled to a polymer backbone by a first linker, (c) optionally a counter ion associated with each nitrogen center, and (d) a hydrolyzable group covalently coupled to each nitrogen center through a second linker, wherein the hydrolyzable group is hydrolyzable to an anionic center to provide a polymer having the anionic center covalently coupled to the nitrogen center through the second linker, the crosslinked polymer having a hydrophilic exterior comprising (a) a polymer backbone, (b) a plurality of nitrogen centers, each nitrogen center covalently coupled to a polymer backbone by a first linker, and (c) an anionic center covalently coupled to each nitrogen center through a second linker, wherein the anionic center is provided via hydrolysis of the hydrolyzable group, wherein the crosslinked polymer comprises a repeating unit having the formula: R 1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C20 alkyl, C6-C12 aryl, and CN groups; R 4 is selected from the group consisting of hydrogen, C1-C20 alkyl, C6-C12 aryl, cyclic alkyl, fluoroalkyl, and void; R 5 is selected from the group consisting of hydrogen, C1-C20 alkyl, C6-C12 aryl, cyclic alkyl, and fluoroalkyl; R 7 is C1-C20 alkyl, C6-C12 aryl, cyclic alkyl, or fluoroalkyl, L is C or Si; L 1 at each occurrence is selected from —(CH 2 ) x —, —(CH(CN)) x —, —C(═O)NH(CH 2 ) x —, —C(═O)O(CH 2 ) x —, —C(═O)OC(═O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, or —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20; L 2 at each occurrence is selected from —(CH 2 ) x — or —(CH(CN)) x —, where x is an integer from 1 to 20; A 1 is N; B 2 is C; and M is selected from Cl, Br, I, SO 4 , NO 3 , ClO 4 , BF 4 , PF 6 , N(SO 2 CF 3 ) 2 , SO 3 CF 3 , RCOO (R is C1-C20 alkyl), lactate, benzoate, salicylate, or void. 2. The bulk material of claim 1 , wherein R 1 is C1-C20 alkyl; R 4 is hydrogen, C1-C20 alkyl, or void; R 5 is hydrogen or C1-C20 alkyl; R 7 is C1-C20 alkyl or cyclic alkyl; L is C; L 1 at each occurrence is —C(═O)NH(CH 2 ) x — or —C(═O)O(CH 2 ) x —; and L 2 is —(CH 2 ) x —. 3. The bulk material of claim 1 , wherein R 1 is methyl. 4. The bulk material of claim 1 , wherein L is C. 5. The bulk material of claim 1 , wherein L 1 is —C(═O)O(CH 2 ) 2 —. 6. The bulk material of claim 1 , wherein R 4 is void and R 5 is methyl. 7. The bulk material of claim 1 , wherein L 2 is —(CH 2 )—. 8. The bulk material of claim 1 , wherein R 7 is methyl, ethyl, cyclopentyl, cyclohexyl, or isonorbornyl. 9. A composite, comprising the bulk material of claim 1 and a second polymer. 10. The composite of claim 9 , wherein the second polymer is selected from the group consisting of polyesters, polycarbonates, polyurethanes, polyureas, polysulfides, polysulfones, polyimides, polyepoxies, aromatic polyesters, cellulosics, fluoropolymers, polyacrylics, polyamides, polyanhydrides, polyethers, vinyl polymers, phenolics, elastomers, and other addition polymers. 11. The composite of claim 9 further comprising a strength additive. 12. The composite of claim 9 further comprising a strength additive selected from the groups consisting of fiber, clays, nanotubes, and other inorganic objects. 13. The bulk material of claim 1 formed by a method selected from the group consisting of injection molding, blow molding, extrusion molding, calendaring molding, flow casting, compression molding, prevarication molding, and 3D printing. 14. A surface coating for a substrate, comprising the bulk material of claim 1 . 15. The surface coating of claim 14 , wherein the substrate is a marine product. 16. The surface coating of claim 14 , wherein the substrate is a marine product selected from the group consisting of marine vessel hulls, marine structures, bridges, propellers, heat exchangers, periscopes, sensors, fish nets, cables, tubes/pipes, containers, membranes, and oil booms. 17. The surface coating of claim 14 , wherein the substrate is a biomedical product. 18. The surface coating of claim 14 , wherein the substrate is a biomedical product selected from the group consisting of catheters, ear drainage tubes, feeding tubes, glaucoma drainage tubes, hydrocephalous shunts, keratoprosthesis, nerve guidance tubes, tissue adhesives, x-ray guides, artificial joints, artificial heart valves, artificial blood vessels, pacemakers, left ventricular assist devices (LVAD), artery grafts, vascular grafts, stents, intravascular stents, cardiac valves, joint replacements, blood vessel prostheses, skin repair devices, cochlear replacements, contact lenses, artificial ligaments and tendons, dental implants, and tissue scaffolds for regenerative tissue engineering. 19. The surface coating of claim 14 , wherein the substrate is a delivery vehicle selected from the group consisting of a drug delivery vehicle, a gene delivery vehicle, an RNA delivery vehicle, and a protein vehicle.
Coating compositions based on macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain (C09D107/00 - C09D157/00, C09D161/00 take precedence); Coating compositions based on derivatives of such polymers · CPC title
Polyesters derived from dicarboxylic acids and dihydroxy compounds (C09D167/06 takes precedence) · CPC title
Carboxylic acids; Esters thereof with monohydroxyl compounds · CPC title
containing cyano groups, amino groups and singly-bound oxygen atoms bound to the carbon skeleton · CPC title
containing heteroatoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.